ArticleJournal for immunotherapy of cancer2021

Potent ex vivo armed T cells using recombinant bispecific antibodies for adoptive immunotherapy with reduced cytokine release.

Jeong A Park et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.